Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03636412 · ClinicalTrials.gov registry record · NA
Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients
A NA study of Sarcopenia and Mobility Limitation, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT03636412: Completed NA study of Sarcopenia and Mobility Limitation, sponsored by The Cleveland Clinic.
NCT03636412 is a NA study of Sarcopenia and Mobility Limitation that has completed, run by The Cleveland Clinic. The registered enrollment target is 200 participants, above the 76-participant average among 41 other Sarcopenia trials with a reported enrollment target (163% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03636412, a NA study of Sarcopenia and Mobility Limitation, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess the feasibility and effectiveness of dedicated ambulator-assisted physical activity in lung transplant inpatients. The primary hypothesis is that an ambulator-assisted intervention for lung transplant patients will prove feasible and may result in improved frailty, hospital outcomes, including less need for inpatient rehabilitation and shorter length of stay in the hospital.
Primary Outcome
The duration of time in days for the index admission for the patient beginning immediately after lung transplant
Conditions Studied
Interventions
- OTHER Ambulation
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2018-08-15 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT03636412 record still lists
NCT03636412 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 76-participant average among 41 other Sarcopenia trials with a reported enrollment target (163% higher).
The record links to 5 conditions, with Sarcopenia appearing as the primary indexed condition, and to 1 intervention - of which Ambulation is the first listed.
NCT03636412 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03636412 about?
NCT03636412 is a clinical study titled "Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients". The objective of this study is to assess the feasibility and effectiveness of dedicated ambulator-assisted physical activity in lung transplant inpatients. The primary hypothesis is that an ambulator-assisted intervention for lung transplant patients will prove feasible and may result in improved fr...
What is the current status of trial NCT03636412?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2018-08-15. Estimated completion is 2024-12-31.
What conditions does trial NCT03636412 study?
This clinical trial studies the following conditions: Sarcopenia, Mobility Limitation, Transplant-Related Disorder, Frail Elderly Syndrome, Lung Graft Dysfunction.
What interventions are being tested in trial NCT03636412?
The interventions under investigation include: Ambulation (OTHER).
Who is sponsoring clinical trial NCT03636412?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03636412 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcopenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03636412's enrollment target sits among peer trials
200 4th of 41 higher than 37 of 41 other Sarcopenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcopenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Spinal Motoneuronal Activation in Older Adults
RECRUITING · NA
-
Strength Training and Resveratrol
RECRUITING · NA
-
Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment
RECRUITING · NA
-
Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX)
RECRUITING · NA
-
C-Protein in Fatigue and Aging
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI